Company Filing History:
Years Active: 2009-2010
Title: Cristina Rossi: Innovator in Non-Peptide Bradykinin Antagonists
Introduction
Cristina Rossi is a prominent inventor based in Pomezia, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of non-peptide bradykinin antagonists. With a total of 2 patents, her work has the potential to impact the treatment of various medical conditions.
Latest Patents
Cristina Rossi's latest patents include innovative compounds that act as selective antagonists of the bradykinin B2 receptor. One of her notable patents describes non-peptide compounds characterized by a general formula that includes various chemical groups. These compounds are designed to treat conditions involving the activation of bradykinin B2 receptors. Another patent focuses on basic non-peptide bradykinin antagonists, which are chemically defined by the presence of an alpha, alpha-disubstituted amino acid. This novel class of medicaments can be utilized in disorders where bradykinin receptors play a crucial role.
Career Highlights
Throughout her career, Cristina has worked with esteemed organizations such as Istituto Luso Farmaco D'Italia S.p.a. and Menarini Ricerche S.p.a. Her experience in these companies has allowed her to refine her expertise in pharmaceutical research and development.
Collaborations
Cristina has collaborated with notable colleagues, including Patrizia Felicetti and Christopher Ingo Fincham. These partnerships have contributed to her innovative research and the successful development of her patents.
Conclusion
Cristina Rossi stands out as a key figure in the pharmaceutical industry, particularly for her work on non-peptide bradykinin antagonists. Her contributions are paving the way for new treatments that could significantly benefit patients with related medical conditions.